Chronic obstructive pulmonary disease in women
https://doi.org/10.12737/artide_5d0ad13e586137.59996983
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
Abstract
Chronic obstructive pulmonary disease (COPD) remains the focus of medical science and practice. The article presents a review of contemporary literature on the problem of COPD in women. The data are presented on the prevalence of the disease, on the characteristics of sensitivity to the effects of risk factors, age-related aspects of development, progression, outcomes and clinical manifestations of COPD, as well as on the difference in response to the pharmacotherapy in women and men. Thus, a number of studies have demonstrated a high susceptibility of women to exposure to tobacco smoke, a predisposition to the development of the bronchitis phenotype of COPD, severe course with frequent exacerbations and a low risk of death after exacerbations. Based on the results of the review, it can be concluded that gender differences can be explained by the anatomical features of the respiratory system development and the cyclic hormonal activity of the female body, which is manifested by a greater degree of airway hyperresponsiveness, and, as a consequence, a high frequency of severe COPD.
About the Authors
O. Yu. KytikovaRussian Federation
Oksana Yu. Kytikova - MD, PhD, Staff scientist of Laboratory of Rehabilitation Treatment.
73g Russkaya Str., Vladivostok, 690105
T. A. Gvozdenko
Russian Federation
73g Russkaya Str., Vladivostok, 690105
V. V. Knyshova
Russian Federation
73g Russkaya Str., Vladivostok, 690105
References
1. World Health Organization. The top ten causes of death. 2011. Fact sheet 310. Available at: https://www.who.int/mediacentre/factsheets/fs310_ 2008.pdf
2. Incidence of the population older than working age (from 55 years for women and from 60 years for men) in Russia in 2017. Statistical materials. Part VII. Moscow; 2018. Available at: https://www.rosminzdrav.ru/ministry/61/22/stranitsa-979/statisticheskie-i-informatsionnye-ma-terialy/statisticheskiy-sbornik-2017-god (in Russian).
3. Kytikova O.Yu., Gvozdenko T.A., Antonyuk M.V. Modern aspects of prevalence of chronic bronchopulmonary diseases. Bulleten'fiziologii ipatologii dyhania 2017; 64:94-100. https://doi.org/10.12737/article_5936346fdfc1f3.32482903 (in Russian).
4. Ovcharenko S.I., Kapustina VA. Features of chronic obstructive pulmonary disease in women. Consilium Medi-cum 2009; 11(3):5-13 (in Russian).
5. Chuchalin A.G., editor. Pulmonology. National guidelines. Moscow: GEOTAR-Media; 2014 (in Russian).
6. Agusti A., Calverley P.M., Celli B., Coxson H.O., Edwards L.D., Lomas D.A., MacNee W., Miller B.E., Ren-nard S., Silverman E.K., Tal-Singer R., Wouters E., Yates J.C., Vestbo J., Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Characterization of COPD heterogeneity in the ECLIPSE cohort. Respir. Res. 2010; 11(1): 122. https://doi.org/10.1186/1465-9921-11-122
7. Almagro P., Lopez Garda F., Cabrera F.J., Montero L., Morchon D., D^ez J., Soriano J.B., Grupo Epoc De La Sociedad Espanola De Medicina Interna. Comorbidity and gender-related differences in patients hospitalized for COPD. The ECCO study. Respir. Med. 2010; 104(2): 253259. https://doi.org/10.1016/j.rmed.2009.09.019
8. American Lung Association. Trends in COPD (chronic bronchitis and emphysema): morbidity and mortality Washington, DC: Americal Lung Association; 2013. Available at: http://www.lung.org/assets/documents/re-search/copd-trend-report.pdf
9. Ancochea J., Miravitlles M., Garda-Rrn F., Munoz L., Sanchez G., Sobradillo V, Duran-Tauleria E., Soriano J.B. Underdiagnosis of chronic obstructive pulmonary disease in women: quantification of the problem, determinants and proposed actions. Arch. Bronconeumol. 2013; 49(6):223-229. https://doi.org/10.1016/j.arbres.2012.11.010
10. Aryal S., Diaz-Guzman E., Mannino D.M. COPD and gender differences: an update. Transl. Res. 2013; 162(4):208-218. https://doi.org/10.1016/j.trsl.2013.04.003
11. Aryal S., Diaz-Guzman E., Mannino D.M. Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes. Int. J. Chron. Obstruct. Pul-mon. Dis. 2014; 9:1145-1154. https://doi.org/10.2147/COPD.S54476
12. Assaggaf H., Felty Q. Gender, estrogen, and obliterative lesions in the lung. Int. J. Endocrinol. 2017; 2017:8475701. https://doi.org/10.1155/2017/8475701
13. Balgoma D., Yang M., Sjodin M., Snowden S., Kar-imi R., Levanen B., Merikallio H., Kaarteenaho R., Palm-berg L., Larsson K., Erle D.J., Dahlen S.E., Dahlen B., Skold C.M., Wheelock A.M., Wheelock C.E. Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD. Eur. Respir. J. 2016; 47(6): 1645-1656. https://doi.org/10.1183/13993003.01080-2015
14. Becklake M., Kauffmann F. Gender differences in airway behaviour over a human life span. Thorax 1999; 54(12): 1119-1138.
15. Burney P. Jithoo A., Kato B., Janson C., Mannino D., Nizankowska-Mogilnicka E., Studnicka M., Tan W., Bateman E., Kogabas A., Vollmer W.M., Gislason T., Marks G., Koul P.A., Harrabi I., Gnatiuc L., Buist S., Burden of Obstructive Lung Disease (BOLD) Study. Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty - a BOLD analysis. Thorax 2014; 69(5):465-473. https://doi.org/10.1136/thoraxjnl-2013-204460
16. Calzetta L., Puxeddu T., Rogliani P. Gender-related responsiveness to the pharmacological treatment of copd: a first step towards the personalized medicine. EBioMedi-cine 2017; 19:14-15. https://doi.org/10.1016/j.ebiom.2017.04.035
17. Chapman K.R., Tashkin D.P., Pye D.J. Gender bias in the diagnosis of COPD. Chest 2001; 119(6):1691-1695.
18. Chen W., Thomas J., Sadatsafavi M., FitzGerald J.M. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir. Med. 2015; 3(8):631-639. https://doi.org/10.1016/S2213-2600(15)00241-6
19. Connett J. Murray R.P., Buist A.S., Wise R.A., Bailey W.C., Lindgren P.G., Owens G.R., Lung Health Study Research Group. Changes in smoking status affect women more than men: results of the lung health study. Am. J. Epidemiol. 2003; 157(11):973-979.
20. European Lung White Book. Chapter 13: Chronic obstructive pulmonary disease. 2016. Available at: http://www.erswhitebook.org/chapters/chronic-obstruc-tive-pulmonary-disease
21. Feenstra T., van Genugten M.L., Hoogenveen R.T., Wouters E.F., Rutten-van Molken M.P. The impact of ageng and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am. J. Respir. Crit. Care Med. 2001; 164(4): 590-596. https://doi.org/10.1164/ajrccm.164.4.2003167
22. Ford E.S., Mannino D.M., Zhao G., Li C., Croft J.B. Changes in mortality among US adults with COPD in two national cohorts recruited from 1971-1975 and 19881994. Chest 2012; 141(1):101-110. https://doi.org/10.1378/chest.11-0472
23. Fuller-Thomson E., Chisholm R.S., Brennenstuhl S. COPD in a population-based sample of never smokers: interactions among sex, gender, and race. Int. J. Chronic Dis. 2016; 2016:5862026. https://doi.org/10.1155/2016/5862026
24. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (GOLD). 2016. Available at: https://goldcopd.org
25. Gonzales A.V., Suissa S., Ernst P. Gender differences in survival following hospitalisation for COPD. Thorax 2011; 66 (1): 38-42. https://doi.org/10.1136/thx.2010.141978
26. Han W., Pentecost B.T., Pietropaolo R.L., Fasco M.J., Spivack S.D. Estrogen receptor alpha increases basal and cigarette smoke extract-induced expression of CYP1A1 and CYP1B1, but not GSTP1, in normal human bronchial epithelial cells. Mol. Carcinog. 2005; 44(3):202-211. https://doi.org/10.1002/mc.20128
27. Hong Y, Ji W., An S., Han S.S., Lee S.J., Kim W.J. Sex differences of COPD phenotypes in nonsmoking patients. Int. J. Chron. Obstruct. Pulmon. Dis. 2016; 11:1657-1662. https://doi.org/10.2147/COPD.S108343
28. Kim Y.I., Schroeder J., Lynch D., Newell J., Make B., Friedlander A., Estepar R.S., Hanania N.A., Washko G., Murphy J.R., Wilson C., Hokanson J.E., Zach J., Butterfield K., Bowler R.P., Copdgene Investigators. Gender differences of airway dimensions in anatomically matched sites on CT in smokers. COPD 2011; 8(4):285-292. https://doi.org/10.3109/15412555.2011.586658
29. Lamprecht B., Soriano J.B., Studnicka M., Kaiser B., Vanfleteren L.E., Gnatiuc L., Burney P, Miravitlles M., Garria-Rio F., Akbari K., Ancochea J., Menezes A.M., Perez-Padilla R., Montes de Oca M., Torres-Duque C.A., Caballero A., Gonzalez-Garda M., Buist S. Determinants of underdiagnosis of COPD in national and international surveys. Chest 2015; 148 (4): 971-985. https://doi.org/10.1378/chest.14-2535
30. Li Y. Dai Y.L., Yu N., Guo Y.M. Sex-related differences in bronchial parameters and pulmonary function test results in patients with chronic obstructive pulmonary disease based on three-dimensional quantitative computed tomography. J. Int. Med. Res. 2018; 46(1): 135-142. https://doi.org/10.1177/0300060517721309
31. Li X., Obeidat M., Zhou G., Leung J.M., Tashkin D., Wise R., Connett J., Joubert P., Bosse Y., van den Berge M., Brandsma C.A., Nickle D.C., Hao K., Pare P.D., Sin D.D. Responsiveness to ipratropium bromide in male and female patients with mild to moderate chronic obstructive pulmonary disease. EBioMedicine 2017; 19:139-145. https://doi.org/10.1016/j.ebiom.2017.04.020
32. Martinez C.H., Raparla S., Plauschinat C.A., Giard-ino N.D., Rogers B., Beresford J., Bentkover J.D., Schachtner-Appel A., Curtis J.L., Martinez F.J., Han M.K. Gender differences in symptoms and care delivery for chronic obstructive pulmonary disease. J. Womens. Health. (Larchmt) 2012; 21(12):1267-1274. https://doi.org/10.1089/jwh.2012.3650.
33. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006; 3(11):e442. https://doi.org/10.1371/journal.pmed.0030442
34. Montserrat-Capdevila J. Godoy P, Marsal J.R., Barbe F., Galvan L. Risk of exacerbation in chronic obstructive pulmonary disease: a primary care retrospective cohort study. BMC Fam. Pract. 2015; 16:173. https://doi.org/10.1186/s12875-015-0387-6
35. Naberan K., Azpeitia A., Cantoni J., Miravitlles M. Impairment of quality of life in women with chronic obstructive pulmonary disease. Respir. Med. 2012; 106(3):367-373. https://doi.org/10.1016/j.rmed.2011.09.014
36. Nattori K., Kida K. Management of older adults with COPD. Nihon Rinsho 2016; 74(5):858-863.
37. Nguyen L.P, Beck E., Cayetano K., Li C.S., Hardin K. Differential pulmonary rehabilitation outcomes in patients with and without COPD: role of gender. J. Cardio-pulm. Rehabil. Prev. 2017; 37(5):350-355. https://doi.org/10.1097/HCR.0000000000000275
38. Okley J.A., Shaheen S., Weiss A., Gale C.R. Wellbeing and chronic lung disease incidence: the survey of health, ageing and retirement in Europe. PLoS One 2017; 12(7): e0181320. https://doi.org/10.1371/journal.pone.018132
39. Patil S.P., Krishnan J.A., Lechtzin M.D., Diette G.B. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch. Intern. Med. 2003; 163(10): 1180-1186. https://doi.org/10.1001/archinte.163.10.1180
40. Roy D., Cai Q., Felty Q., Narayan S. Estrogen-induced generation of reactive oxygen and nitrogen species, gene damage, and estrogen-dependent cancers. J. Toxicol. Environ. Health B Crit. Rev. 2007; 10(4): 235-257. https://doi.org/10.1080/15287390600974924
41. Salvi S.S., Barnes P.J. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009; 374(9691):733-743. https://doi.org/10.1016/S0140-6736(09)61303-9
42. S0rheim I.C., Johannessen A., Gulsvik A., Bakke P.S., Silverman E.K., DeMeo D.L. Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax 2010; 65(6):480-485. https://doi.org/10.1136/thx.2009.122002
43. Stallberg B. Janson C., Johansson G., Larsson K., Stratelis G., Telg G., Lisspers K.H. Management, morbidity and mortality of COPD during an 11-year period: an observational retrospective epidemiological register study in Sweden (PATHOS). Prim. Care Respir. J. 2014; 23(1):38-45. https://doi.org/10.4104/pcrj.2013.00106
44. Tam A., Churg A., Wright J.L., Zhou S., Kirby M., Coxson H., Lam S., Man S.F., Sin D.D. Sex differences in airway remodeling in a mouse model of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2016; 193(8):825-834. https://doi.org/10.1164/rccm.201503-0487OC
45. To T., Zhu J., Villeneuve P.J., Simatovic J., Feldman L. , Gao C., Williams D., Chen H., Weichenthal S., Wall C., Miller A.B. Chronic disease prevalence in women and air pollution - a 30-year longitudinal cohort study. Environ. Int. 2015; 80:26-32. https://doi.org/10.1016/j.envint.2015.03.017
46. Tsiligianni I., Rodriguez M.R., Lisspers K., LeeTan T., Infantino A. Call to action: improving primary care for women with COPD. NPJ Prim. Care Respir. Med. 2017; 27(1): 11. https://doi.org/10.1038/s41533-017-0013-2
47. van Boven J.F., Roman-Rodriguez M., Palmer J.F., Toledo-Pons N., Cosfo B.G., Soriano J.B. Comorbidome, pattern, and impact of asthma-COPD overlap syndrome in real life. Chest 2016; 149(4):1011-1020. https://doi.org/10.1016/j.chest.2015.12.002
48. Varol Y, Anar C., Qimen P. Unlu M., Halilgolar H., Guglu S.Z. Sex-related differences in COPD Assessment Test scores of COPD populationswith or without significant anxiety and/or depression. Turk. J. Med. Sci. 2017; 47(1):61-68. https://doi.org/10.3906/sag-1509-60
49. Vogelmeier CF., Criner G.J., Martinez F.J., Anzueto A., Barnes P.J., Bourbeau J., Celli B.R., Chen R., Decramer M., Fabbri L.M., Frith P., Halpin D.M., Lopez Varela M.V, Nishimura M., Roche N., Rodriguez-Roisin R., Sin D.D., Singh D., Stockley R., Vestbo J., Wedzicha J.A., Agusri A. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2017; 195(5):557-582. https://doi.org/10.1164/rccm.201701-0218PP
50. Vozoris N.T., Stanbrook M.B. Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma. Respir. Med. 2011; 105(3):477-484. https://doi.org/10.1016/j.rmed.2010.08.011
51. World Health Organization. Chronic obstructive pulmonary disease (COPD). Fact sheet №315. Geneva: WHO; 2015. Available at: http://www.who.int/mediac-entre/factsheets/fs315/en
Review
For citations:
Kytikova O.Yu., Gvozdenko T.A., Knyshova V.V. Chronic obstructive pulmonary disease in women. Bulletin Physiology and Pathology of Respiration. 2019;(72):103-111. (In Russ.) https://doi.org/10.12737/artide_5d0ad13e586137.59996983